Empreendimentos Pague Menos SA banner

Empreendimentos Pague Menos SA
BOVESPA:PGMN3

Watchlist Manager
Empreendimentos Pague Menos SA Logo
Empreendimentos Pague Menos SA
BOVESPA:PGMN3
Watchlist
Price: 6.45 BRL 2.06%
Market Cap: R$4.3B

Empreendimentos Pague Menos SA
Investor Relations

Empreendimentos Pague Menos SA engages in the retail of medicine, perfumes, toiletries, beauty products, cosmetics, and skin care products. The company is headquartered in Fortaleza, Ceara and currently employs 25,701 full-time employees. The company went IPO on 2020-09-02. Through a drugstore chain, the Company sells medicines, perfumes, personal care and household products, cosmetics, as well as grocery goods, among others. Additionally, It offers a range of financial services, such as bill collection and credit card issuing. The firm also operates a call center that provides information related to drugs usage.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 4, 2025
AI Summary
Q3 2025

Same-Store Sales: Pague Menos posted same-store sales growth of 17.6%, marking four consecutive quarters above 17% and outpacing inflation by about 5 times.

Revenue Growth: Total revenue rose 18%, with prescription drugs and generics driving strong structural growth across all regions.

EBITDA Margin: Record quarterly EBITDA margin reached 6.3%, up 36.4% year-over-year, driven by higher sales, improved margins, and expense dilution.

Net Income: Net income hit BRL 81 million for the quarter (up 50% YoY) and BRL 231 million LTM, a sharp turnaround from losses in 2023.

Market Share: Market share rose to 6.7% (up 40 bps YoY), with particularly strong gains in the Northeast region.

Customer Base: Active customers grew 5% to 22.2 million, with increased average ticket size and frequency from continuous care customers.

Working Capital: Working capital days increased due to higher installment sales of fast-growing drugs like GLP-1s, but management expects improvement from stricter installment policies.

Black Friday & Strategy: Management highlighted a major Black Friday campaign and reaffirmed focus on operational discipline, customer care, and efficiency gains.

Key Financials
Same-Store Sales Growth
17.6%
EBITDA Margin
6.3%
EBITDA
BRL 260 million
Net Income
BRL 81 million (quarter); BRL 231 million (LTM)
Market Share
6.7%
Active Customers
22.2 million
Average Sales Per Store Per Month
BRL 831,000
Stores with Sales Above BRL 1 Million
Over 26% of stores
GLP-1 Share of Sales
7%
Popular Pharmacy Share of Sales
4%
Net Debt to EBITDA
2.5x
Earnings Call Recording
Other Earnings Calls

Management

Mr. Jonas Marques
CEO and VP of Operations, People, Commercial & Supply
No Bio Available
Mr. Luiz Renato Novais
Chief Financial & Investor Relations Officer and Chief Expansion Officer
No Bio Available
Afro Jose Campos de Vasconcelos
Director of Infrastructure & Technology
No Bio Available
Renato Camargo Nascimento Jr.
Vice President of Marketing & Customer Relations
No Bio Available

Contacts

Address
CEARA
Fortaleza
Rua Senador Pompeu, 1520, Centro
Contacts